SBI-102

N/A

Report date: 2024/11/20 16:40:08

Base Information

Drug NameSBI-102
Drug Alias NameStem cell-derived exosomes expressing a therapeutic ligand(ShiftBio)SBI-102SIRP-EV
ClassificationBiologics
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShiftBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShiftBio Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A